Clinical trial
Hematopoietic Stem Cell Therapy for Patients With Multiple Sclerosis
NCT00278655 · Northwestern University, Other · Terminated
Key facts
| NCT number | NCT00278655 |
|---|---|
| Title | Hematopoietic Stem Cell Therapy for Patients With Multiple Sclerosis |
| Official title | Hematopoietic Stem Cell Therapy for Patients With Inflammatory Multiple Sclerosis Failing Interferon Therapy: A Phase II Multi-Center Trial |
| Lead sponsor | Northwestern University, Other |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Biological |
| Interventions | Hematopoietic stem cell transplantation |
| Enrollment | 21 |
| Start date | Jun 1, 2003 |
| Primary completion | Dec 1, 2011 |
| Completion | May 1, 2012 |
| First posted | Jan 18, 2006 |
| Last update posted | May 1, 2014 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: